17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found
      Current Behavioral Neuroscience Reports
      treatment, suicide, trials, mechanisms, suicidality, ketamine

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose of Review:

          Given recent increases in rates of suicide and lack of rapid treatments for suicidality, ketamine has been identified as a potential fast-acting anti-suicidal treatment. Our review seeks to describe the effects of ketamine on suicidality, given the growing literature on the use of ketamine in reducing suicidality. We examine open-label studies and randomized controlled trials evaluating treatment of suicidality with ketamine. Furthermore, our manuscript identifies potential mechanisms of ketamine’s effects on suicidality.

          Recent Findings:

          Based on existing RCTs, ketamine appears to have rapid anti-suicidal effects, with most literature studying such effects in timeframes less than one week. Although still in the early stages of research, mechanisms of ketamine include modulation of molecular, inflammatory, neural, cognitive, and behavioral processes.

          Summary:

          Thus, ketamine appears to be a promising treatment for suicidality, but requires larger scale and more robust RCTs to confirm the potential use of this agent in clinical settings.

          Related collections

          Author and article information

          Journal
          101626570
          42290
          Curr Behav Neurosci Rep
          Curr Behav Neurosci Rep
          Current behavioral neuroscience reports
          2196-2979
          2 December 2019
          2 December 2019
          December 2019
          15 January 2021
          : 6
          : 4
          : 166-176
          Affiliations
          [a ]Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA
          [b ]University of Pittsburgh School of Medicine, Pittsburgh, PA
          Author notes
          Corresponding author: Rebecca B. Price, Western Psychiatric Institute and Clinic, 3811 O’Hara St., Pittsburgh, PA 15213, Phone: 412-648-6445, Fax: 412-631-8947, rebecca.price@ 123456stanfordalumni.org .
          Article
          PMC7809881 PMC7809881 7809881 nihpa1544964
          10.1007/s40473-019-00184-3
          7809881
          33457182
          2e1410c2-b67c-4edc-9b75-4af586a71d07
          History
          Categories
          Article

          treatment,suicide,trials,mechanisms,suicidality,ketamine
          treatment, suicide, trials, mechanisms, suicidality, ketamine

          Comments

          Comment on this article